IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-03720-z.html
   My bibliography  Save this article

Somatic activating mutations in MAP2K1 cause melorheostosis

Author

Listed:
  • Heeseog Kang

    (National Institutes of Health)

  • Smita Jha

    (National Institutes of Health
    National Institutes of Health)

  • Zuoming Deng

    (National Institutes of Health)

  • Nadja Fratzl-Zelman

    (1st Medical Department Hanusch Hospital, UKH Meidling)

  • Wayne A. Cabral

    (National Institutes of Health
    National Institutes of Health)

  • Aleksandra Ivovic

    (National Institutes of Health)

  • Françoise Meylan

    (National Institutes of Health)

  • Eric P. Hanson

    (National Institutes of Health)

  • Eileen Lange

    (National Institutes of Health)

  • James Katz

    (National Institutes of Health)

  • Paul Roschger

    (1st Medical Department Hanusch Hospital, UKH Meidling)

  • Klaus Klaushofer

    (1st Medical Department Hanusch Hospital, UKH Meidling)

  • Edward W. Cowen

    (National Institutes of Health)

  • Richard M. Siegel

    (National Institutes of Health)

  • Joan C. Marini

    (National Institutes of Health)

  • Timothy Bhattacharyya

    (National Institutes of Health)

Abstract

Melorheostosis is a sporadic disease of uncertain etiology characterized by asymmetric bone overgrowth and functional impairment. Using whole exome sequencing, we identify somatic mosaic MAP2K1 mutations in affected, but not unaffected, bone of eight unrelated patients with melorheostosis. The activating mutations (Q56P, K57E and K57N) cluster tightly in the MEK1 negative regulatory domain. Affected bone displays a mosaic pattern of increased p-ERK1/2 in osteoblast immunohistochemistry. Osteoblasts cultured from affected bone comprise two populations with distinct p-ERK1/2 levels by flow cytometry, enhanced ERK1/2 activation, and increased cell proliferation. However, these MAP2K1 mutations inhibit BMP2-mediated osteoblast mineralization and differentiation in vitro, underlying the markedly increased osteoid detected in affected bone histology. Mosaicism is also detected in the skin overlying bone lesions in four of five patients tested. Our data show that the MAP2K1 oncogene is important in human bone formation and implicate MEK1 inhibition as a potential treatment avenue for melorheostosis.

Suggested Citation

  • Heeseog Kang & Smita Jha & Zuoming Deng & Nadja Fratzl-Zelman & Wayne A. Cabral & Aleksandra Ivovic & Françoise Meylan & Eric P. Hanson & Eileen Lange & James Katz & Paul Roschger & Klaus Klaushofer &, 2018. "Somatic activating mutations in MAP2K1 cause melorheostosis," Nature Communications, Nature, vol. 9(1), pages 1-12, December.
  • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03720-z
    DOI: 10.1038/s41467-018-03720-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-03720-z
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-018-03720-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03720-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.